Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and paclitaxel

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with paclitaxel in 3 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(paclitaxel)		Trials
(paclitaxel)		Recent Studies (post-2010) (paclitaxel)
9,15618755231,8745,72915,395

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)paclitaxel (IC50)
Integrin beta-3Homo sapiens (human)0.034
Integrin alpha-V Homo sapiens (human)0.034
ATP-dependent translocase ABCB1Homo sapiens (human)2.598
Botulinum neurotoxin type A Clostridium botulinum5.2
UDP-glucuronosyltransferase 2B7Homo sapiens (human)4.9
UDP-glucuronosyltransferase 1-6Homo sapiens (human)4.9
Substance-K receptorHomo sapiens (human)6.125
UDP-glucuronosyltransferase 1A1 Homo sapiens (human)4.9
UDP-glucuronosyltransferase 1A4Homo sapiens (human)4.9
UDP-glucuronosyltransferase 2B10 Homo sapiens (human)4.9
Delta-type opioid receptorHomo sapiens (human)4.202
Tyrosine-protein kinase MerHomo sapiens (human)4.9
Tubulin beta-3 chainHomo sapiens (human)0.0082
Beta-tubulin Leishmania donovani1
Nucleotide-binding oligomerization domain-containing protein 2Homo sapiens (human)7.9433
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)0.26
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.28

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Brinkley, BR; Clark, GD; McNeil, RS; Swann, JW1
Berthou, C; Bourge, JF; Denizot, Y; Fleet, C; Geromin, D; Leboulch, P; Michel, E; Pawliuk, R; Sasportes, M; Sigaux, F; Soulié, A1
Han, C; Li, L; Li, M; Liu, Y; Mao, Y; Song, S; Wang, Z; Xu, B; Yu, G; Zhou, L1

Other Studies

3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and paclitaxel

ArticleYear
Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue.
    Cell motility and the cytoskeleton, 1999, Volume: 43, Issue:2

    Topics: Actins; Animals; Cells, Cultured; Cytochalasin D; Cytoskeleton; Fluorescent Antibody Technique, Indirect; Microtubules; Mitochondria; Neurites; Neurons; Nocodazole; Paclitaxel; Phospholipid Ethers; Platelet Activating Factor; Polymers; Rats; Rats, Sprague-Dawley

1999
Glycoprotein 170 induces platelet-activating factor receptor membrane expression and confers tumor cell hypersensitivity to NK-dependent cell lysis.
    Journal of immunology (Baltimore, Md. : 1950), 2004, Mar-15, Volume: 172, Issue:6

    Topics: ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Embryonal; Cell Line, Tumor; Cell Membrane; Clone Cells; Cytotoxicity, Immunologic; Drug Resistance, Neoplasm; Genes, MDR; Glycoproteins; Humans; Hydrogen-Ion Concentration; K562 Cells; Killer Cells, Natural; Leukemia, Erythroblastic, Acute; Paclitaxel; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Retroviridae; Teratoma; Transduction, Genetic; Transfection

2004
LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
    PloS one, 2020, Volume: 15, Issue:11

    Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Indoles; Male; Mice; Paclitaxel; PC-3 Cells; Platelet Activating Factor; Prostatic Neoplasms, Castration-Resistant; Up-Regulation

2020